NSC745885 is a potent anti-tumor agent with selective cytotoxicity against various cancer cell lines while showing no toxicity toward normal cells; it acts as a potent downregulator of EZH2 via the proteasome degradation pathway; it shows potential for the research and treatment of advanced bladder cancer and oral squamous cell carcinoma.